157 related articles for article (PubMed ID: 30197514)
1. Magnetic nanoparticle hyperthermia potentiates paclitaxel activity in sensitive and resistant breast cancer cells.
Rivera-Rodriguez A; Chiu-Lam A; Morozov VM; Ishov AM; Rinaldi C
Int J Nanomedicine; 2018; 13():4771-4779. PubMed ID: 30197514
[TBL] [Abstract][Full Text] [Related]
2. Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy.
Giovinazzi S; Bellapu D; Morozov VM; Ishov AM
Cell Cycle; 2013 Aug; 12(16):2598-607. PubMed ID: 23907120
[TBL] [Abstract][Full Text] [Related]
3. Short-term hyperthermia promotes the sensitivity of MCF-7 human breast cancer cells to paclitaxel.
Lin Y; Liu Z; Li Y; Liao X; Liao S; Cen S; Yang L; Wei J; Hu X
Biol Pharm Bull; 2013; 36(3):376-83. PubMed ID: 23229357
[TBL] [Abstract][Full Text] [Related]
4. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
5. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge".
Zhao W; Li T; Long Y; Guo R; Sheng Q; Lu Z; Li M; Li J; Zang S; Zhang Z; He Q
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25701-25714. PubMed ID: 34041901
[TBL] [Abstract][Full Text] [Related]
6. Cancer cell membrane-coated mesoporous silica loaded with superparamagnetic ferroferric oxide and Paclitaxel for the combination of Chemo/Magnetocaloric therapy on MDA-MB-231 cells.
Cai D; Liu L; Han C; Ma X; Qian J; Zhou J; Zhu W
Sci Rep; 2019 Oct; 9(1):14475. PubMed ID: 31597929
[TBL] [Abstract][Full Text] [Related]
7. Crocin enhances the sensitivity to paclitaxel in human breast cancer cells by reducing BIRC5 expression.
Jia Y; Yang H; Yu J; Li Z; Jia G; Ding B
Chem Biol Drug Des; 2024 Feb; 103(2):e14467. PubMed ID: 38661582
[TBL] [Abstract][Full Text] [Related]
8. Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models.
Lugert S; Unterweger H; Mühlberger M; Janko C; Draack S; Ludwig F; Eberbeck D; Alexiou C; Friedrich RP
Int J Nanomedicine; 2019; 14():161-180. PubMed ID: 30613144
[TBL] [Abstract][Full Text] [Related]
9. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines.
Wang Y; Yu L; Han L; Sha X; Fang X
Int J Pharm; 2007 Jun; 337(1-2):63-73. PubMed ID: 17289311
[TBL] [Abstract][Full Text] [Related]
10. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
[TBL] [Abstract][Full Text] [Related]
12. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
Baek JS; Cho CW
J Pharm Pharmacol; 2013 Jan; 65(1):72-8. PubMed ID: 23215690
[TBL] [Abstract][Full Text] [Related]
13. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer.
Bu H; He X; Zhang Z; Yin Q; Yu H; Li Y
Int J Pharm; 2014 Aug; 471(1-2):206-13. PubMed ID: 24866272
[TBL] [Abstract][Full Text] [Related]
14. Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition.
Meng L; Xia X; Yang Y; Ye J; Dong W; Ma P; Jin Y; Liu Y
Int J Pharm; 2016 Nov; 513(1-2):8-16. PubMed ID: 27596118
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and evaluation of aptamer-conjugated paclitaxel-loaded magnetic nanoparticles for targeted therapy on breast cancer cells.
Khodadadi E; Mahjoub S; Arabi MS; Najafzadehvarzi H; Nasirian V
Mol Biol Rep; 2021 Mar; 48(3):2105-2116. PubMed ID: 33635469
[TBL] [Abstract][Full Text] [Related]
16. Resistance to Intervention: Paclitaxel in Breast Cancer.
Dan VM; Raveendran RS; Baby S
Mini Rev Med Chem; 2021; 21(10):1237-1268. PubMed ID: 33319669
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel Nanoparticles Induce Apoptosis and Regulate TXR1, CYP3A4 and CYP2C8 in Breast Cancer and Hepatoma Cells.
Diab T; Alkafaas SS; Shalaby TI; Hessien M
Anticancer Agents Med Chem; 2020; 20(13):1582-1591. PubMed ID: 32364081
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Profiling of Paclitaxel Treated Cells Identifies a Novel Mechanism of Drug Resistance Mediated by PDCD4.
Xu H; Dephoure N; Sun H; Zhang H; Fan F; Liu J; Ning X; Dai S; Liu B; Gao M; Fu S; Gygi SP; Zhou C
J Proteome Res; 2015 Jun; 14(6):2480-91. PubMed ID: 25928036
[TBL] [Abstract][Full Text] [Related]
19. Hyperthermic enhancement of the apoptotic and antiproliferative activities of paclitaxel.
Othman T; Goto S; Lee JB; Taimura A; Matsumoto T; Kosaka M
Pharmacology; 2001 May; 62(4):208-12. PubMed ID: 11359996
[TBL] [Abstract][Full Text] [Related]
20. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
Giannakakou P; Robey R; Fojo T; Blagosklonny MV
Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]